We employ open IHC platforms to develop, test, and validate custom protocols using new or already established antibodies for our clients
We provide IHC services for analysis of research and clinical trial samples in our CLIA laboratory with protocols transferred from a client or developed in-house
Our pathologists develop scoring guidelines and review slides routinely